Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) appeared recently and now presents a particularly critical problem to hospitalized patients worldwide. We aim to investigate the epidemiology and the risk factors for CRKP colonization and infections, and to evaluate the application perfo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2020.00462/full |
id |
doaj-700fa9220143496f8486de75cf047e6a |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lili Fang Lili Fang Lili Fang Heping Xu Heping Xu Heping Xu Xiaoying Ren Xiaoying Ren Xiaoying Ren Xun Li Xun Li Xun Li Xiaobo Ma Xiaobo Ma Xiaobo Ma Haijian Zhou Haijian Zhou Guolin Hong Guolin Hong Guolin Hong Xianming Liang Xianming Liang |
spellingShingle |
Lili Fang Lili Fang Lili Fang Heping Xu Heping Xu Heping Xu Xiaoying Ren Xiaoying Ren Xiaoying Ren Xun Li Xun Li Xun Li Xiaobo Ma Xiaobo Ma Xiaobo Ma Haijian Zhou Haijian Zhou Guolin Hong Guolin Hong Guolin Hong Xianming Liang Xianming Liang Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study Frontiers in Cellular and Infection Microbiology carbapenems resistance Klebsiella pneumonia carbapenem-resistant Klebsiella pneumonia MALDI-TOF MS |
author_facet |
Lili Fang Lili Fang Lili Fang Heping Xu Heping Xu Heping Xu Xiaoying Ren Xiaoying Ren Xiaoying Ren Xun Li Xun Li Xun Li Xiaobo Ma Xiaobo Ma Xiaobo Ma Haijian Zhou Haijian Zhou Guolin Hong Guolin Hong Guolin Hong Xianming Liang Xianming Liang |
author_sort |
Lili Fang |
title |
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study |
title_short |
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study |
title_full |
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study |
title_fullStr |
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study |
title_full_unstemmed |
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study |
title_sort |
epidemiology and risk factors for carbapenem-resistant klebsiella pneumoniae and subsequent maldi-tof ms as a tool to cluster kpc-2-producing klebsiella pneumoniae, a retrospective study |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cellular and Infection Microbiology |
issn |
2235-2988 |
publishDate |
2020-09-01 |
description |
Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) appeared recently and now presents a particularly critical problem to hospitalized patients worldwide. We aim to investigate the epidemiology and the risk factors for CRKP colonization and infections, and to evaluate the application performance of MALDI-TOF MS in clustering CRKP.Results: CRKP colonization and infections incidence was 2.7 (35/1,319,427) per 100,000 patient-days. Inpatients in CRKP group had higher medical expense than CSKP group. Inpatients with underlying conditions, particularly with pulmonary diseases, and with antimicrobial use prior to culture within 30 days, especially with carbapenem use, were risk factors for CRKP acquisition. All CRKP isolates were detected producing KPC-2. The MALDI-TOF MS system and PFGE system provided similar results, with a good concordance between the two methods (adjusted Rand's coefficient, 0.846) and a high probability of MALDI-TOF MS to predict PFGE results (Wallace coefficient, 0.908).Conclusions: Underlying conditions, particularly pulmonary diseases, and antimicrobial use prior to culture within 30 days, especially carbapenem use, are risk factors for CRKP acquisition. BlaKPC−2 is the mainstream gene of CRKP in our geographic area of analysis. As only simple sample preparation is needed and the results can be obtained in a short time, MALDI-TOF MS may be considered a probable alternative to PFGE in clustering KPC-2-producing CRKP. |
topic |
carbapenems resistance Klebsiella pneumonia carbapenem-resistant Klebsiella pneumonia MALDI-TOF MS |
url |
https://www.frontiersin.org/article/10.3389/fcimb.2020.00462/full |
work_keys_str_mv |
AT lilifang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT lilifang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT lilifang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT hepingxu epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT hepingxu epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT hepingxu epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xiaoyingren epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xiaoyingren epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xiaoyingren epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xunli epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xunli epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xunli epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xiaoboma epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xiaoboma epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xiaoboma epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT haijianzhou epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT haijianzhou epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT guolinhong epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT guolinhong epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT guolinhong epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xianmingliang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy AT xianmingliang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy |
_version_ |
1724678023441022976 |
spelling |
doaj-700fa9220143496f8486de75cf047e6a2020-11-25T03:05:32ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882020-09-011010.3389/fcimb.2020.00462545210Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective StudyLili Fang0Lili Fang1Lili Fang2Heping Xu3Heping Xu4Heping Xu5Xiaoying Ren6Xiaoying Ren7Xiaoying Ren8Xun Li9Xun Li10Xun Li11Xiaobo Ma12Xiaobo Ma13Xiaobo Ma14Haijian Zhou15Haijian Zhou16Guolin Hong17Guolin Hong18Guolin Hong19Xianming Liang20Xianming Liang21Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaState Key Laboratory for Infectious Disease Prevention and Control, Chinese Center for Disease Control and Prevention, National Institute for Communicable Disease Control and Prevention, Beijing, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaCenter of Clinical Laboratory, School of Medicine, Zhongshan Hospital, Xiamen University, Xiamen, ChinaInstitute of Infectious Disease, School of Medicine, Xiamen University, Xiamen, ChinaBackground: Carbapenem-resistant Klebsiella pneumoniae (CRKP) appeared recently and now presents a particularly critical problem to hospitalized patients worldwide. We aim to investigate the epidemiology and the risk factors for CRKP colonization and infections, and to evaluate the application performance of MALDI-TOF MS in clustering CRKP.Results: CRKP colonization and infections incidence was 2.7 (35/1,319,427) per 100,000 patient-days. Inpatients in CRKP group had higher medical expense than CSKP group. Inpatients with underlying conditions, particularly with pulmonary diseases, and with antimicrobial use prior to culture within 30 days, especially with carbapenem use, were risk factors for CRKP acquisition. All CRKP isolates were detected producing KPC-2. The MALDI-TOF MS system and PFGE system provided similar results, with a good concordance between the two methods (adjusted Rand's coefficient, 0.846) and a high probability of MALDI-TOF MS to predict PFGE results (Wallace coefficient, 0.908).Conclusions: Underlying conditions, particularly pulmonary diseases, and antimicrobial use prior to culture within 30 days, especially carbapenem use, are risk factors for CRKP acquisition. BlaKPC−2 is the mainstream gene of CRKP in our geographic area of analysis. As only simple sample preparation is needed and the results can be obtained in a short time, MALDI-TOF MS may be considered a probable alternative to PFGE in clustering KPC-2-producing CRKP.https://www.frontiersin.org/article/10.3389/fcimb.2020.00462/fullcarbapenemsresistanceKlebsiella pneumoniacarbapenem-resistant Klebsiella pneumoniaMALDI-TOF MS |